66493-03-6

Basic information

• Product Name: methyl cyclohexanecarboximidate
• Synonyms: methyl cyclohexanecarboximidate
• CAS NO: 66493-03-6
• Molecular Weight: 141.213
• Mol File: 66493-03-6.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 174.4±23.0 °C(Predicted)
• Density: 1.04±0.1 g/cm3(Predicted)
• CAS DataBase Reference: methyl cyclohexanecarboximidate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl cyclohexanecarboximidate(66493-03-6)
• EPA Substance Registry System: methyl cyclohexanecarboximidate(66493-03-6)

Safety Data

• Hazardous Substances Data: 66493-03-6(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 766-05-2 cyclohexane carbonitrile 

Downstream Products

• 68175-68-8 C₁₅H₂₂N₂O 
• 68175-69-9 C₁₄H₁₉ClN₂O 
• 99355-51-8 methyl N-(phenylacetyl)cyclohexanecarboximidate 
• 2498-48-8 cyclohexanecarboximidamide hydrochloride 
• 1059172-90-5 4-chloro-2-cyclohexyl-5,6-dimethylpyrimidine 
• 897005-70-8 2-cyclohexyl-5,6-dimethylpyrimidin-4-ol 
• 1059172-66-5 N-(2-cyclohexyl-5,6-dimethylpyrimidin-4-yl)-5-fluoro-1H-pyrazolo[3,4-b]pyridin-3-amine 
• 99355-52-9 N-(methoxycyclohexylmethyl)phenylacetamide 

Relevant articles and documents

PYRIMIDINES AND PYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES

The present invention relates to compounds useful as inhibitors of protein kinases, such as inhibitors of GSK-3. The invention provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. The invention provides processes for preparing compounds of the invention. The invention provides methods of identifying compounds useful for treatment of diabetes, diabetic neuropathy, osteoporosis, Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS-associated dementia, bipolar disorder, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia, leukocytopenia, cardiomyocyte hypertrophy, stroke, post-stroke, spinal cord injury, traumatic brain injury, Charcot-Marie-Tooth, peripheral nerve regeneration, and rheumatoid arthritis.